Carlos Correa rejoined the Houston Astros lineup on Friday, April 11, 2026, after being sidelined for two games with an illness. His return comes as the Minnesota Twins continue to grapple with the long-term implications of trading him to the Astros in 2025, a move that significantly impacted both teams’ rosters and financial flexibility.
Correa’s absence was felt keenly by the Astros, who suffered a 9-1 defeat and a three-game sweep by the Rockies in Colorado, highlighting the impact of his bat on the team’s offense, as reported by clutchpoints.com.
Houston Astros manager Joe Espada confirmed that Correa had been ‘under the weather,’ causing him to miss consecutive games. Despite the illness, Correa remained with the team, participating in light activities and avoiding a potential move to the injured list, according to MLB.com’s Manny Randhawa.
Correa, a three-time All-Star, has transitioned to third base this season, a shift from his primary shortstop role. This move, made after his reacquisition by the Astros, accommodates All-Star Jeremy Pena at shortstop and adds defensive versatility to the team.
Early in the 2026 season, Correa demonstrated strong offensive performance, recording 11 hits, one home run, and nine RBIs in 11 games. His return is expected to boost the Astros, who currently hold a 6-7 record and sit third in the AL West, ahead of their series against the Seattle Mariners.
Meanwhile, the Minnesota Twins are still analyzing the trade that sent Correa back to Houston. The move, which involved the Twins paying the Astros $10 million per season, was initially meant to create financial flexibility, as detailed by twinsdaily.com.
However, instead of reinvesting the savings, the Twins’ payroll dropped from $136 million in 2025 to $107 million in 2026, leading to a leaner roster without significant optimization. Analysts suggest that retaining Correa’s over $30 million annual contract would have necessitated different roster decisions, potentially involving trading key players like Pablo López, Joe Ryan, or Ryan Jeffers.
Correa’s tenure with the Twins was marked by both highs and lows, including a 5.3 rWAR season in 2022 and an All-Star appearance in the first half of 2024. However, he also battled plantar fasciitis, raising durability concerns.
The trade also had ripple effects on the Twins’ roster, influencing free agent acquisitions such as Josh Bell and Victor Caratini, and potentially altering the roles for prospects like Brooks Lee and Luke Keaschall. The question remains whether the Twins are truly better off without Correa, given their current financial and roster situation, or if they sufficiently capitalized on the flexibility the trade offered.
